APOC1 and hepatocellular carcinoma: APOC1 expression was found to be negatively correlated with programmed death-1 receptor (PD-1) and its ligand (PD-L1) in human HCC samples, suggesting new insights for anti-PD-1 immunotherapy in HCC.